Calcium Channel Antagonist

Calcium Channel Antagonists (56):

Cat. No.	Product Name	Effect	Purity

HY-14275

Verapamil	Antagonist	99.96%
Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor.

HY-B0284

Nifedipine	Antagonist	99.05%
Nifedipine (BAY-a-1040) is a potent calcium channel blocker and drug of choice for cardiac insufficiencies.

HY-A0064

Verapamil hydrochloride	Antagonist	99.98%
Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor.

HY-14656

Diltiazem hydrochloride	Antagonist	99.50%
Diltiazem hydrochloride is a Ca²⁺ influx inhibitor (slow channel blocker or calcium antagonist).

HY-B1077

Penfluridol	Antagonist	99.93%
Penfluridol is a highly potent, first generation diphenylbutylpiperidine antipsychotic.

HY-103315

Bepridil hydrochloride	Antagonist	99.76%
Bepridil hydrochloride (CERM 1978) is a calcium channel blocker, with antianginal activity.

HY-Z0816

Dehydronitrosonisoldipine	Antagonist	≥98.0%
Dehydronitrosonisoldipine, a derivative of Nisoldipine (HY-17402), is an irreversible and cell-permeant sterile alpha and TIR motif-containing 1 (SARM1) inhibitor.

HY-B0317B

Amlodipine besylate	Antagonist	99.92%
Amlodipine besylate (Amlodipine benzenesulfonate), an antianginal agent and an orally active dihydropyridine calcium channel blocker, works by blocking the voltage-dependent L-type calcium channels, thereby inhibiting the initial influx of calcium.

HY-111828

TTA-A2	Antagonist	≥99.0%
TTA-A2 is a potent, selective and orally active t-type voltage gated calcium channel antagonist with reduced pregnane X receptor (PXR) activation.

HY-14284

Nilvadipine	Antagonist	99.96%
Nilvadipine is a potent calcium channel antagonist, and the IC₅₀ value is around 0.1 nM.

HY-16952A

Bepridil hydrochloride hydrate	Antagonist	99.73%
Bepridil hydrochloride hydrate ((±)-Bepridil hydrochloride hydrate) is a non-selective, long-acting Ca⁺ channel antagonist and Na⁺, K⁺ channel inhibitor, with antianginal and type I antiarrhythmic effects.

HY-10388

TTA-Q6	Antagonist	99.97%
TTA-Q6 is a selective T-type Ca²⁺ channel antagonist, which can be used in the research of neurological disease.

HY-116408A

Propiverine hydrochloride	Antagonist	98.93%
Propiverine hydrochloride is a bladder spasmolytic with calcium antagonistic and anticholinergic properties.

HY-B0549A

Flavoxate hydrochloride	Antagonist	99.89%
Flavoxate hydrochloride is a potent and competitive phosphodiesterase (PDE) inhibitor.

HY-108974

Drotaverine hydrochloride	Antagonist	99.48%
Drotaverine (hydrochloride) is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor and an L-type voltage-dependent calcium channel (L-VDCC) blocker, blocks the degradation of 3',5'-cyclic adenosine monophosphate.

HY-B0317A

Amlodipine maleate	Antagonist	99.87%
Amlodipine maleate is a dihydropyridine calcium channel blocker, acts as an orally active antianginal agent.

HY-14276A

Gallopamil hydrochloride	Antagonist	≥98.0%
Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist.

HY-U00212

Aranidipine	Antagonist	98.67%
Aranidipine (MPC1304) is a Ca²⁺ channel antagonist with potent and long-lasting antihypertensive effects.

HY-103318

PD173212	Antagonist	98.43%
PD173212 is a selective N-type voltage sensitive calcium channel (VSCC) blocker, with an IC₅₀ of 36 nM in IMR-32 assays.

HY-17436

Clevidipine	Antagonist	99.88%
Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension.

Name
Email *

	Sorry, but the email address you supplied was invalid.